Bryant Fong

Filings by Bryant Fong span 2 companies, the busiest being Adma Biologics, Inc. and Neos Therapeutics, Inc. The record holds 9 filings, for trades running from 31 August 2016 to 26 February 2024.

In open-market terms, that means 1 purchase worth €8,790 on one side and 1 sale worth €5.1M on the other. Netting one side against the other leaves €5.1M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 6 share grants.

The latest filing, published on 28 February 2024, reports a share grant in Adma Biologics, Inc. The latest purchase dates back some time: it was published 3,721 days ago, on 31 August 2016. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.